| Date | TitleTitle | |||
|---|---|---|---|---|
| 07/03/25 | 12:04:25 | 7 Mar 2025 | Result of General Meeting | |
| 04/03/25 | 12:00:22 | 4 Mar 2025 | Director/PDMR Shareholding | |
| 24/02/25 | 16:31:26 | 24 Feb 2025 | Holding(s) in Company | |
| 19/02/25 | 11:04:20 | 19 Feb 2025 | £4.25m Placing and Subscription, Notice of GM | |
| 19/02/25 | 10:54:39 | 19 Feb 2025 | Appointment of Dr Alastair Smith as Chair | |
| 28/11/24 | 07:00:03 | 28 Nov 2024 | Half-year Report | |
| 27/11/24 | 07:00:12 | 27 Nov 2024 | European Patent Office award decision | |
| 15/11/24 | 10:58:07 | 15 Nov 2024 | Holding(s) in Company | |
| 14/11/24 | 15:24:41 | 14 Nov 2024 | Issue of Equity and Total Voting Rights | |
| 14/11/24 | 11:00:00 | 14 Nov 2024 | Notice of Results | |
| 11/11/24 | 07:00:10 | 11 Nov 2024 | Publication of peer reviewed data | |
| 04/11/24 | 11:00:00 | 4 Nov 2024 | Passing of Dr Sue Foden, Chair | |
| 29/08/24 | 07:00:11 | 29 Aug 2024 | Grant of Options and PDMR Dealings | |
| 08/08/24 | 10:23:14 | 8 Aug 2024 | Holding(s) in Company | |
| 18/07/24 | 15:02:00 | 18 Jul 2024 | Result of AGM | |
| 17/07/24 | 10:26:48 | 17 Jul 2024 | Holding(s) in Company | |
| 16/07/24 | 12:50:57 | 16 Jul 2024 | Holding(s) in Company | |
| 10/07/24 | 14:00:01 | 10 Jul 2024 | Publication of peer-reviewed data on SFX-01 | |
| 21/06/24 | 09:00:00 | 21 Jun 2024 | Annual Financial Report and Notice of AGM | |
| 13/06/24 | 15:14:29 | 13 Jun 2024 | Holding(s) in Company | |
| 13/06/24 | 07:00:11 | 13 Jun 2024 | TheraCryf Research and Development Day | |
| 04/06/24 | 15:04:48 | 4 Jun 2024 | Holding(s) in Company | |
| 28/05/24 | 16:05:53 | 28 May 2024 | Final Results - Correction | |
| 28/05/24 | 07:00:17 | 28 May 2024 | Final Results | |
| 22/05/24 | 07:00:10 | 22 May 2024 | Notice of R&D presentation | |
| 20/05/24 | 07:00:11 | 20 May 2024 | Notice of Results | |
| 02/05/24 | 10:47:02 | 2 May 2024 | Holding(s) in Company | |
| 02/05/24 | 07:00:11 | 2 May 2024 | Chronos Integration Update | |
| 02/05/24 | 07:00:08 | 2 May 2024 | Total Voting Rights | |
| 25/04/24 | 15:46:56 | 25 Apr 2024 | Change of Name | |
| 22/04/24 | 10:11:56 | 22 Apr 2024 | Holding(s) in Company | |
| 11/04/24 | 15:04:50 | 11 Apr 2024 | Holding(s) in Company | |
| 09/04/24 | 07:00:12 | 9 Apr 2024 | Holding(s) in Company | |
| 08/04/24 | 16:03:15 | 8 Apr 2024 | Holding(s) in Company | |
| 05/04/24 | 15:39:31 | 5 Apr 2024 | Director/PDMR Shareholding | |
| 05/04/24 | 14:40:59 | 5 Apr 2024 | Holding(s) in Company | |
| 04/04/24 | 13:59:09 | 4 Apr 2024 | Result of General Meeting | |
| 04/04/24 | 07:00:05 | 4 Apr 2024 | Result of Retail Offer | |
| 19/03/24 | 17:03:43 | 19 Mar 2024 | Retail Offer | |
| 19/03/24 | 17:00:00 | 19 Mar 2024 | Acquisition, Fundraising and Change of Name | |
| 27/02/24 | 07:00:10 | 27 Feb 2024 | SFX-01 positive update in bowel cancer models | |
| 19/02/24 | 11:22:01 | 19 Feb 2024 | Positive update on SFX-01 in vitro GBM studies | |
| 09/02/24 | 11:01:01 | 9 Feb 2024 | Notice of Dispute lodged with Stalicla SA | |
| 16/01/24 | 15:07:32 | 16 Jan 2024 | Series B Fund Raise by partner, Stalicla SA | |
| 29/12/23 | 11:29:54 | 29 Dec 2023 | Holding(s) in Company | |
| 22/12/23 | 07:00:06 | 22 Dec 2023 | Directorate Changes | |
| 13/11/23 | 07:00:14 | 13 Nov 2023 | Upcoming conferences | |
| 31/10/23 | 07:00:12 | 31 Oct 2023 | Half-year Report | |
| 26/10/23 | 07:00:14 | 26 Oct 2023 | Erasmus Medical Center begins glioblastoma studies | |
| 19/10/23 | 14:26:29 | 19 Oct 2023 | Authored Article Publication |
| Date | TitleTitle | |||
|---|---|---|---|---|
| 07/03/25 | 12:04:25 | 7 Mar 2025 | Result of General Meeting | |
| 04/03/25 | 12:00:22 | 4 Mar 2025 | Director/PDMR Shareholding | |
| 24/02/25 | 16:31:26 | 24 Feb 2025 | Holding(s) in Company | |
| 19/02/25 | 11:04:20 | 19 Feb 2025 | £4.25m Placing and Subscription, Notice of GM | |
| 19/02/25 | 10:54:39 | 19 Feb 2025 | Appointment of Dr Alastair Smith as Chair | |
| 28/11/24 | 07:00:03 | 28 Nov 2024 | Half-year Report | |
| 27/11/24 | 07:00:12 | 27 Nov 2024 | European Patent Office award decision | |
| 15/11/24 | 10:58:07 | 15 Nov 2024 | Holding(s) in Company | |
| 14/11/24 | 15:24:41 | 14 Nov 2024 | Issue of Equity and Total Voting Rights | |
| 14/11/24 | 11:00:00 | 14 Nov 2024 | Notice of Results | |
| 11/11/24 | 07:00:10 | 11 Nov 2024 | Publication of peer reviewed data | |
| 04/11/24 | 11:00:00 | 4 Nov 2024 | Passing of Dr Sue Foden, Chair | |
| 29/08/24 | 07:00:11 | 29 Aug 2024 | Grant of Options and PDMR Dealings | |
| 08/08/24 | 10:23:14 | 8 Aug 2024 | Holding(s) in Company | |
| 18/07/24 | 15:02:00 | 18 Jul 2024 | Result of AGM | |
| 17/07/24 | 10:26:48 | 17 Jul 2024 | Holding(s) in Company | |
| 16/07/24 | 12:50:57 | 16 Jul 2024 | Holding(s) in Company | |
| 10/07/24 | 14:00:01 | 10 Jul 2024 | Publication of peer-reviewed data on SFX-01 | |
| 21/06/24 | 09:00:00 | 21 Jun 2024 | Annual Financial Report and Notice of AGM | |
| 13/06/24 | 15:14:29 | 13 Jun 2024 | Holding(s) in Company | |
| 13/06/24 | 07:00:11 | 13 Jun 2024 | TheraCryf Research and Development Day | |
| 04/06/24 | 15:04:48 | 4 Jun 2024 | Holding(s) in Company | |
| 28/05/24 | 16:05:53 | 28 May 2024 | Final Results - Correction | |
| 28/05/24 | 07:00:17 | 28 May 2024 | Final Results | |
| 22/05/24 | 07:00:10 | 22 May 2024 | Notice of R&D presentation | |
| 20/05/24 | 07:00:11 | 20 May 2024 | Notice of Results | |
| 02/05/24 | 10:47:02 | 2 May 2024 | Holding(s) in Company | |
| 02/05/24 | 07:00:11 | 2 May 2024 | Chronos Integration Update | |
| 02/05/24 | 07:00:08 | 2 May 2024 | Total Voting Rights | |
| 25/04/24 | 15:46:56 | 25 Apr 2024 | Change of Name | |
| 22/04/24 | 10:11:56 | 22 Apr 2024 | Holding(s) in Company | |
| 11/04/24 | 15:04:50 | 11 Apr 2024 | Holding(s) in Company | |
| 09/04/24 | 07:00:12 | 9 Apr 2024 | Holding(s) in Company | |
| 08/04/24 | 16:03:15 | 8 Apr 2024 | Holding(s) in Company | |
| 05/04/24 | 15:39:31 | 5 Apr 2024 | Director/PDMR Shareholding | |
| 05/04/24 | 14:40:59 | 5 Apr 2024 | Holding(s) in Company | |
| 04/04/24 | 13:59:09 | 4 Apr 2024 | Result of General Meeting | |
| 04/04/24 | 07:00:05 | 4 Apr 2024 | Result of Retail Offer | |
| 19/03/24 | 17:03:43 | 19 Mar 2024 | Retail Offer | |
| 19/03/24 | 17:00:00 | 19 Mar 2024 | Acquisition, Fundraising and Change of Name | |
| 27/02/24 | 07:00:10 | 27 Feb 2024 | SFX-01 positive update in bowel cancer models | |
| 19/02/24 | 11:22:01 | 19 Feb 2024 | Positive update on SFX-01 in vitro GBM studies | |
| 09/02/24 | 11:01:01 | 9 Feb 2024 | Notice of Dispute lodged with Stalicla SA | |
| 16/01/24 | 15:07:32 | 16 Jan 2024 | Series B Fund Raise by partner, Stalicla SA | |
| 29/12/23 | 11:29:54 | 29 Dec 2023 | Holding(s) in Company | |
| 22/12/23 | 07:00:06 | 22 Dec 2023 | Directorate Changes | |
| 13/11/23 | 07:00:14 | 13 Nov 2023 | Upcoming conferences | |
| 31/10/23 | 07:00:12 | 31 Oct 2023 | Half-year Report | |
| 26/10/23 | 07:00:14 | 26 Oct 2023 | Erasmus Medical Center begins glioblastoma studies | |
| 19/10/23 | 14:26:29 | 19 Oct 2023 | Authored Article Publication |
